ISR scale | Total sample | Treatment over 1 year | Treatment over 2 years | |
---|---|---|---|---|
ES after completion of treatment | ES after completion of treatment | ES before completion of treatment | ES after completion of treatment | |
ES (Tmax-T0)b | ES (T1-T0) | ES (T1-T0)c | ES (T2-T0)d | |
ES (95 % CI) | ES (95 % CI) | ES (95 % CI) | ES (95 % CI) | |
Depressive symptoms | Positive clinical diagnosis of depressive disorder | |||
n = 208 0.58 (0.44,0.71) | n = 159 0.56 (0.41,0.72) | n = 49 0.37 (0.09,0.65) | n = 49 0.61 (0.33,0.90) | |
Anxiety symptoms | Positive clinical diagnosis of anxiety disorder | |||
n = 128 0.45 (0.29,0.62) | n = 100 0.44 (0.26,0.63) | n = 28 0.44 (0.12,0.76) | n = 28 0.49 (0.11,0.87) | |
Obsessive-compulsive disorder symptoms | Positive clinical diagnosis of obsessive-compulsive disorder | |||
n = 43 0.54 (0.31,0.77) | n = 30 0.57 (0.30,0.84) | n = 13 0.23 (–0.24,0.71) | n = 13 0.47 (–0.05,0.99) | |
Somatoform symptoms | Positive clinical diagnosis of somatoform disorder | |||
n = 94 0.31 (0.15,0.48) | n = 67 0.39 (0.18,0.60)* | n = 27 0.04 (–0.16,0.23)* | n = 27 0.13 (–0.10,0.37) | |
Eating disorder symptoms | Positive clinical diagnosis of eating disorder | |||
n = 68 0.29 (0.07,0.52) | n = 51 0.35 (0.10,0.60)* | n = 17 –0.21 (–0.58,0.16)* | n = 17 0.13 (–0.41,0.67) |